Chemical formula: C₁₆H₂₄N₂O Molecular mass: 260.375 g/mol PubChem compound: 5095
Ropinirole is indicated for:
Population group: only adults (18 years old or older)
Initial treatment as monotherapy, in order to delay the introduction of levodopa.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Ropinirole is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
